T. Aarvak et al., Switch in chemokine receptor phenotype on memory T cells without a change in the cytokine phenotype, SC J IMMUN, 54(1-2), 2001, pp. 100-108
Th1 and Th2 cells as defined by their cytokine profile are associated with
the expression of the chemokine receptors CCR5 and CCR3, respectively. In c
ommitted human memory Th1 cells the cytokine profile is irreversibly expres
sed. However, it is not known if the chemokine receptor phenotypes of Th1 a
nd Th2 cells are permanently associated to the cytokine profile or if it ca
n be changed. To analyze the possibility of inducing a switch in chemokine
receptor phenotype on memory Th cells we used differentiated memory Th cell
s isolated from synovial tissue (ST) samples of patients with rheumatoid ar
thritis (RA), Freshly isolated T cells, T-cell Lines and T-cell clones from
these tissues were manipulated with Th1 (interleukin (IL)-12 + anti IL-4)
or Th2 (IL-4 + anti IL-12) inducing conditions. The surface expression of C
CR5 and CCR3 was analyzed by flowcytometry and interferon (IFN)-gamma and I
L-4 production by ELISA, A Th1-inducing cytokine environment increased the
expression of CCR5 in Th1 cells and induced the expression of CCR5 in Th2 c
ells as compared to culture condition with only IL-2, Induction of CCR5 exp
ression on Th2 clones was associated with secretion of some IFN-gamma. More
over, the Th2-associated chemokine receptor CCR3 could be expressed on both
Th1-dominant cell lines, and clones of Th1 and Th0 type after culture cond
itions with IL-4,This expression of CCR3 was associated with a reduced IFN-
gamma production, but no IL-4 production could be induced. The IL-4-treated
Th1 clones had a reduced migratory capacity against chemokines produced by
ST cells compared to nonmanipulated T-cell clones. In contrast, thr same I
L-12-treated Th1 clones showed an increased migratory potential. Induction
of the Th2-associated marker CCR3 on memory Th1 cells demonstrates that a c
hange in chemokine receptor phenotype related to the Th2 type can be induce
d on terminally differentiated Th1 cells, without a change in the cytokine
profile.